Perrigo | PRGO - Sales Revenues

Perrigo Ordinary Shares reported $1.1B in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Abbott ABT:US USD 10.09B 319M
Abbvie ABBV:US USD 15.12B 309M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Catalent CTLT:US USD 1.15B 127M
Dr.Reddys Laboratories DRRD:IN INR 67.9B 4.58B
Eli Lilly And LLY:US USD 7.3B 360.2M
Endo International Ordinary Shares ENDP:US USD 541.69M 27.42M
Johnson & Johnson JNJ:US USD 23.71B 85M
Lannett LCI:US USD 80.89M 5.82M
Merk MRK:US USD 13.83B 1.13B
Pfizer PFE:US USD 24.29B 1.65B
Prestige Brands PBH:US USD 275.52M 13.75M
Teva Pharmaceutical TEVA:IT USD 3.88B 289M
Zoetis ZTS:US USD 2.04B 38M